Antimicrobial and Antibiofilm Activity of Nanomaterials: From Bacteria to Yeast
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Materials and Surfaces".
Deadline for manuscript submissions: closed (15 October 2024) | Viewed by 6467
Special Issue Editors
Interests: antimicrobial metallic nanoparticles; biofilms; microbiome; nanotoxicology
Special Issue Information
Dear Colleagues,
The recent surge of Multi-Drug Resistant diseases and the current COVID-19 pandemic have exposed our vulnerability to infectious diseases and the urgency of developing novel solutions. As of today, infections are among the leading causes of death in developed and developing countries. Bacteria and fungal infections negatively impact health, life quality, food production, and transportation. In particular, biofilm-forming microorganisms pose an additional risk in healthcare and food-processing settings. Antimicrobial nanomaterials are a promising approach to combat pathogens and disrupt bacterial and fungal biofilms. Current research highlights antimicrobial nanomaterials' use to detect, prevent, and combat pathogens and biofilms. In addition, some nanomaterials display synergistic effects when combined with antimicrobial drugs and disinfectants.
This Special Issue seeks manuscript submissions that expand our understanding of the impact of antimicrobial nanomaterials on microbial cell physiology and structure, biofilms, the microbiome, and antimicrobial drugs/antiseptics/disinfectants. Submissions that address the interactions between antimicrobial nanomaterials and microbial cells are particularly encouraged.
Dr. Roberto Vazquez-Munoz
Dr. Lourdes Bazán-Díaz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial nanomaterials
- antibiofilm
- microbiome
- drug resistance
- nanotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.